Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,174
Out of 4,893 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $10.26 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $66.85 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $297.40 | +7.60% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $89.40 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $32.09 | +49.58% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $166.67 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $8.75 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $134.71 | -40.61% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $7.49 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $53.32 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $133.60 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $103.86 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $85.46 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $78.80 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.26
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $66.85
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $297.40
Upside: +7.60%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $89.40
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $32.09
Upside: +49.58%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $166.67
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $8.75
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $134.71
Upside: -40.61%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $7.49
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $53.32
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $133.60
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $103.86
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $85.46
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $78.80
Upside: -